| Primary |
| Diabetes Mellitus |
13.8% |
| Product Used For Unknown Indication |
13.8% |
| Type 2 Diabetes Mellitus |
12.5% |
| Drug Use For Unknown Indication |
8.8% |
| Hypertension |
7.5% |
| Hypertension Arterial |
5.0% |
| Anxiety |
3.8% |
| Diabetes Mellitus Non-insulin-dependent |
3.8% |
| Non-insulin-dependent Diabetes Mellitus |
3.8% |
| Sciatica |
3.8% |
| Cardiac Failure |
2.5% |
| Depression |
2.5% |
| Diabetes |
2.5% |
| Dyslipidaemia |
2.5% |
| Erysipelas |
2.5% |
| Gout |
2.5% |
| Maternal Exposure Timing Unspecified |
2.5% |
| Pain |
2.5% |
| Parkinson's Disease |
2.5% |
| Arrhythmia |
1.3% |
|
| Renal Failure Acute |
17.2% |
| Hypoglycaemia |
10.3% |
| Vomiting |
10.3% |
| Hypoglycaemic Coma |
6.9% |
| Cryptogenic Organizing Pneumonia |
3.4% |
| Foetal Malformation |
3.4% |
| Hepatic Cirrhosis |
3.4% |
| Ischaemia |
3.4% |
| Jaundice |
3.4% |
| Loss Of Consciousness |
3.4% |
| Malaise |
3.4% |
| Metabolic Acidosis |
3.4% |
| Oliguria |
3.4% |
| Pancreatic Carcinoma |
3.4% |
| Pancreatitis |
3.4% |
| Pancreatitis Acute |
3.4% |
| Rash Pustular |
3.4% |
| Renal Failure |
3.4% |
| Renal Failure Chronic |
3.4% |
| Shock |
3.4% |
|
| Secondary |
| Type 2 Diabetes Mellitus |
26.9% |
| Product Used For Unknown Indication |
16.3% |
| Hypertension |
12.7% |
| Drug Use For Unknown Indication |
10.0% |
| Diabetes Mellitus |
3.9% |
| Dyslipidaemia |
3.6% |
| Overdose |
3.6% |
| Anxiety |
2.4% |
| Gastrooesophageal Reflux Disease |
2.1% |
| Atrial Fibrillation |
1.8% |
| Cardiac Failure |
1.8% |
| Depression |
1.8% |
| Erysipelas |
1.8% |
| Gout |
1.8% |
| Pain |
1.8% |
| Rheumatoid Arthritis |
1.8% |
| Colorectal Cancer Metastatic |
1.5% |
| Hiv Infection |
1.5% |
| Thrombosis Prophylaxis |
1.5% |
| Colorectal Cancer |
1.2% |
|
| Renal Failure |
12.7% |
| Renal Failure Acute |
9.5% |
| Hypoglycaemia |
7.9% |
| Depressed Level Of Consciousness |
6.3% |
| Jaundice |
6.3% |
| Pancreatic Carcinoma |
6.3% |
| Cholestasis |
4.8% |
| Renal Tubular Necrosis |
4.8% |
| Somnolence |
4.8% |
| Vomiting |
4.8% |
| Generalised Oedema |
3.2% |
| Myocardial Infarction |
3.2% |
| Pancreatitis Acute |
3.2% |
| Pancytopenia |
3.2% |
| Rash |
3.2% |
| Respiratory Tract Congestion |
3.2% |
| Rhabdomyolysis |
3.2% |
| Toxicity To Various Agents |
3.2% |
| Vitamin D Deficiency |
3.2% |
| Weight Decreased |
3.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
21.6% |
| Type 2 Diabetes Mellitus |
16.0% |
| Hypertension |
13.6% |
| Diabetes Mellitus |
11.8% |
| Drug Use For Unknown Indication |
8.1% |
| Mantle Cell Lymphoma |
4.1% |
| Depression |
3.1% |
| Postoperative Wound Infection |
2.8% |
| Hiv Infection |
2.5% |
| Prophylaxis |
2.5% |
| Multiple Myeloma |
2.0% |
| Hypercholesterolaemia |
1.7% |
| Breast Cancer |
1.5% |
| Atrial Fibrillation |
1.4% |
| Hypothyroidism |
1.4% |
| Thrombosis Prophylaxis |
1.4% |
| Induction Of Anaesthesia |
1.3% |
| Pulmonary Arterial Hypertension |
1.3% |
| Adenocarcinoma |
1.0% |
| Hepatitis C |
1.0% |
|
| Vomiting |
19.0% |
| Hypoglycaemia |
7.0% |
| Renal Failure Acute |
7.0% |
| Urinary Retention |
7.0% |
| Renal Failure |
5.0% |
| Septic Shock |
5.0% |
| Aplasia Pure Red Cell |
4.0% |
| Fatigue |
4.0% |
| Hyperglycaemia |
4.0% |
| Orthostatic Hypotension |
4.0% |
| Pyrexia |
4.0% |
| Rectal Haemorrhage |
4.0% |
| Weight Decreased |
4.0% |
| Weight Increased |
4.0% |
| Anaphylactic Shock |
3.0% |
| Breast Cancer |
3.0% |
| Congestive Cardiomyopathy |
3.0% |
| Hodgkin's Disease |
3.0% |
| Lactic Acidosis |
3.0% |
| Obstructive Airways Disorder |
3.0% |
|
| Interacting |
| Drug Use For Unknown Indication |
47.6% |
| Type 2 Diabetes Mellitus |
33.3% |
| Hypoglycaemia |
9.5% |
| Diabetes Mellitus |
4.8% |
| Hypertension |
4.8% |
|
| Hypoglycaemic Coma |
40.0% |
| Hypoglycaemia |
20.0% |
| Renal Failure Acute |
20.0% |
| Skin Ulcer |
20.0% |
|
